🔥🐔 BizChicken 🐔🔥
Companies Similar to Halozyme Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Enliven Therapeutics, Inc.
small molecule kinase inhibitors
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule inhibitors for cancer treatment, including key products ELVN-001 and ELVN-002 under clinical trials.
About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About | Vision/Values
Symbol: ELVN
Recent Price: $22.39
Industry: Biotechnology
CEO: Mr. Samuel S. Kintz M.B.A.
Sector: Healthcare
Employees: 52
Address: 6200 Lookout Road, Boulder, CO 80301
Phone: 720 647 8519
Leadership
- Sam Kintz, Co-founder, Chief Executive Officer, and Member of the Board of Directors
- Joe Lyssikatos, Co-founder, Chief Scientific Officer
- Anish Patel, Co-founder and Chief Operating Officer
- Helen Collins, Chief Medical Officer
- Ben Hohl, Chief Financial Officer and Head of Corporate Development
- Galya Blachman, Chief Legal Officer and Head of Business Development
- Rich A. Heyman, Chairman of the Board of Directors
- Rishi Gupta, Member of the Board of Directors
- Andy Phillips, Member of the Board of Directors
- Mika Kakefuda Derynck, Member of the Board of Directors
- Jake Bauer, Member of the Board of Directors
- Rahul Ballal, Member of the Board of Directors
- Lori Kunkel, Member of the Board of Directors
- Brian Druker, Scientific Advisor
- Kevin Koch, Scientific Advisor
Last updated: 2024-12-31
Gain Therapeutics, Inc.
Site-Directed Enzyme Enhancement Therapy platform
Gain Therapeutics, Inc. is a biotechnology company developing therapies for diseases caused by protein misfolding, focusing on rare genetic diseases and neurological disorders. It utilizes its proprietary technology to discover and develop molecules targeting misfolded proteins.
Symbol: GANX
Recent Price: $2.18
Industry: Biotechnology
CEO: Mr. Gene Mack M.B.A.
Sector: Healthcare
Employees: 29
Address: 4800 Montgomery Lane, Bethesda, MD 20814
Phone: 301 500 1556
Last updated: 2024-12-31
Dynavax Technologies Corporation
HEPLISAV-B
Dynavax Technologies Corporation is a biopharmaceutical company focusing on the development and commercialization of novel vaccines, including HEPLISAV-B, a hepatitis B vaccine. It collaborates with several international partners and is headquartered in Emeryville, California.
About | About | ESG | Contact | Contact | Careers | Careers | Benefits | About | About | Careers | Careers | Vision/Values
Symbol: DVAX
Recent Price: $12.83
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Ryan Spencer
Sector: Healthcare
Employees: 408
Address: 2100 Powell Street, EmeryVille, CA 94608
Phone: 510 848 5100
Last updated: 2024-12-31
Amgen Inc.
Enbrel, Neulasta, Prolia, Xgeva, Otezla, Aranesp, KYPROLIS, Repatha, Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide, focusing on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience.
Jobs | About | About | History | Vision/Values | Leadership | Awards | About | ESG | About | About | About | Contact | About | DEI | About | About | About | About | About | About | About | About | Jobs | Jobs | Jobs | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Careers | Careers | Benefits | Careers | Locations | Events | Jobs | Careers | Careers | Careers | Site Map | Management | Careers | About | About | About | About | About | About | About | Jobs | Jobs | Jobs | Jobs
Symbol: AMGN
Recent Price: $259.30
Industry: Drug Manufacturers - General
CEO: Mr. Robert A. Bradway
Sector: Healthcare
Employees: 26700
Address: One Amgen Center Drive, Thousand Oaks, CA 91320-1799
Phone: 805 447 1000
Leadership
- Robert A. Bradway, Chairman and Chief Executive Officer
- James Bradner, Executive Vice President, Research and Development, and Chief Scientific Officer
- Sean Bruich, Senior Vice President Artificial Intelligence and Data
- Paul Burton, Senior Vice President and Chief Medical Officer
- Raymond Deshaies, Senior Vice President, Global Research
- Jackie Elbonne, Senior Vice President, Quality and Chief Quality Officer
- Murdo Gordon, Executive Vice President, Global Commercial Operations
- Jonathan Graham, Executive Vice President and General Counsel and Secretary
- Peter Griffith, Executive Vice President and Chief Financial Officer
- Nancy Grygiel, Senior Vice President, Worldwide Compliance & Business Ethics and Chief Compliance Officer
- Narimon Honarpour, Senior Vice President, Global Development
- Vikram Karnani, Executive Vice President, and President, Global Commercial Operations and Medical Affairs (Rare Disease)
- My Linh Kha, Senior Vice President and General Manager, Japan Asia-Pacific
- Rachna Khosla, Senior Vice President, Business Development
- Gilles Marrache, Senior Vice President, Regional General Manager
- Derek Miller, Senior Vice President, Human Resources
- Jerry Murry, Senior Vice President, Process Development
- Kave Niksefat, Senior Vice President, Global Marketing and Access
- Arleen Paulino, Senior Vice President, Manufacturing
- Annalisa Pizzarello, Senior Vice President, Results Delivery Office
- Greg Portner, Senior Vice President, Global Government Affairs and Policy
- Anton Rabushka, Senior Vice President, Finance
- Emily Razaqi, Senior Vice President, Obesity and Related Conditions
- David M. Reese, Executive Vice President and Chief Technology Officer
- Esteban Santos, Executive Vice President, Operations
- Darryl Sleep, Senior Vice President, Global Medical
- Jean-Charles Soria, Senior Vice President, Research and Development
- Susan Sweeney, Executive Vice President, Obesity and Related Conditions
- Mark J. Taisey, Senior Vice President, Global Regulatory Affairs and Strategy
- Susie Tappouni, Head of Corporate Affairs
- Ian Thompson, Senior Vice President, U.S. Business Operations
- Brenda Torres, Senior Vice President, Global Supply Chain
- Alper Üreten, Vice President, Commercialization and Program Management
- Wanda M. Austin, Retired President and Chief Executive Officer, The Aerospace Corporation
- Michael V. Drake, President, University of California
- Brian J. Druker, Physician-Scientist and Professor of Medicine, Oregon Health & Science University (OHSU), Director of the OHSU Knight Cancer Institute and JELD-WEN Chair of Leukemia Research, and Associate Dean for Oncology, OHSU School of Medicine
- Robert A. Eckert, Lead Independent Director, Chairman Emeritus, Mattel, Inc.
- Greg C. Garland, Former Executive Chairman and Former Chairman and Chief Executive Officer, Phillips 66
- Charles M. Holley, Jr., Former Executive Vice President and Chief Financial Officer of Wal-Mart Stores, Inc.
- S. Omar Ishrak, Former Executive Chairman and Chairman of the Board of Directors, Medtronic plc
- Tyler Jacks, David H. Koch Professor of Biology, Massachusetts Institute of Technology and Founding Director of the David H. Koch Institute for Integrative Cancer Research
- Mary E. Klotman, Executive Vice President for Health Affairs of Duke University, Dean of the Duke University School of Medicine, and Chief Academic Officer of Duke Health
- Ellen J. Kullman, Executive Chair of the Board and Former President and Chief Executive Officer of Carbon, Inc.
- Amy E. Miles, Former Chair of the Board and Chief Executive Officer, Regal Entertainment Group, Inc.
Last updated: 2024-12-31
Halozyme Therapeutics, Inc.
ENHANZE drug delivery technology
Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.
Symbol: HALO
Recent Price: $47.99
Industry: Biotechnology
CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Sector: Healthcare
Employees: 373
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone: 858 794 8889
Last updated: 2024-12-31
Sangamo Therapeutics, Inc.
ZFP Technology Platform
Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company that develops genomic medicines using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation with a focus on transforming patients' lives.
Contact | About | About | Leadership | Leadership | About | About | About | About | About | About | About | About | About | About | Careers | Vision/Values | DEI | Benefits | About | About | About | About | About | About | About | News | Events | Vision/Values | DEI | Benefits | Careers | Careers | About | About
Symbol: SGMO
Recent Price: $2.34
Industry: Biotechnology
CEO: Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Sector: Healthcare
Employees: 405
Address: 501 Canal Blvd, Brisbane California, CALIFORNIA 94005
Phone: 510 970 6000
Leadership
- Sandy Macrae, M.B., Ch.B., Ph.D.,
- Gregory Davis, Ph.D., Head of Research and Technology
- Nathalie Dubois-Stringfellow, Ph.D., Chief Development Officer
- Prathyusha Duraibabu, Chief Financial Officer
- Phillip Ramsey, Head of Technical Operations
- Stephanie J. Seiler, CLP, Head of Business Development & Alliance Management
- Louise Wilkie, Global Corporate Communications and Investor Relations
- Scott Willoughby, General Counsel and Corporate Secretary
- H. Stewart Parker, Chair of the Board
- Courtney Beers, Ph.D.,
- Robert Carey,
- Kenneth Hillan, M.B. Ch.B.,
- Margaret (Peg) A. Horn, J.D.,
- John Markels, Ph.D.,
- James R. Meyers,
- Karen Smith, M.D., Ph.D., M.B.A., LLM,
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Enzo Biochem, Inc.
Life Sciences Products
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company specializing in the research, development, manufacture, and marketing of diagnostic and research products using genetic engineering, biotechnology, and molecular biology. It operates through segments focused on Life Sciences Products, Clinical Laboratory Services, and Therapeutics.
About | About | About | About | About | Leadership | Locations | About | About | About | About | Careers | Benefits | Careers | About | Jobs | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | About | About | About | About
Symbol: ENZ
Recent Price: $0.70
Industry: Medical - Diagnostics & Research
CEO: Ms. Kara Cannon
Sector: Healthcare
Employees: 125
Address: 527 Madison Avenue, New York, NY 10022
Phone: 212 583 0100
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Ensysce Biosciences, Inc.
PF614, PF614-MPAR, PF329
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company focused on developing prescription drugs for severe pain relief and opioid overdose protection using proprietary abuse-resistant technologies.
Symbol: ENSC
Recent Price: $8.62
Industry: Biotechnology
CEO: Dr. D. Lynn Kirkpatrick Ph.D.
Sector: Healthcare
Employees: 7
Address: 7946 Ivanhoe Avenue, La Jolla, CA 92037
Phone: 858 263 4196
Last updated: 2024-12-31
Heron Therapeutics, Inc.
SUSTOL, CINVANTI, ZYNRELEF
Heron Therapeutics, Inc. is a biotechnology company focused on developing treatments to address unmet patient needs, utilizing its proprietary Biochronomer drug delivery technology.
About | Management | Directors | About | Contact | Careers | About | Careers | Jobs | Careers
Symbol: HRTX
Recent Price: $1.51
Industry: Biotechnology
CEO: Mr. Craig Alexander Collard
Sector: Healthcare
Employees: 126
Address: 4242 Campus Point Court, San Diego, CA 92121
Phone: 858 251 4400
Leadership
- Adam Morgan, Chairman
- Sharmila Dissanaike, M.D., FACS, FCCM, Director
- Craig Johnson, Lead Independent Director
- Susan Rodriguez, Director
- Christian Waage, Director
- Craig Collard, Director
- Brett Fleshman, Chief Business Officer
Last updated: 2024-12-31
Humacyte, Inc.
Human Acellular Vessels (HAVs)
Humacyte, Inc. develops and manufactures off-the-shelf, implantable, and bioengineered human tissues for various therapeutic areas, focusing on human acellular vessels (HAVs) for vascular repair and other medical needs.
Symbol: HUMA
Recent Price: $5.09
Industry: Biotechnology
CEO: Dr. Laura E. Niklason M.D., Ph.D.
Sector: Healthcare
Employees: 183
Address: 2525 East North Carolina Highway 54, Durham, NC 27713
Phone: 919 313 9633
Last updated: 2024-12-31
Inozyme Pharma, Inc.
INZ-701
Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.
Symbol: INZY
Recent Price: $2.82
Industry: Biotechnology
CEO: Dr. Douglas A. Treco Ph.D.
Sector: Healthcare
Employees: 59
Address: 321 Summer Street, Boston, MA 02210
Phone: 857 330 4340
Leadership
- Doug Treco, Ph.D., CEO, Chairman of Board of Directors
- Gayle Gironda, Senior Vice President and Chief People Officer
- Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
- Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
- Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
- Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
- Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
- Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
- David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
- Sarah Bhagat, Ph.D., Director
- Reinaldo M. Diaz, MBA, Director
- Martin Edwards M.D., MBA, Director
- Erik Harris, MBA, Director
- Rob Hopfner, Rph, Ph.D., MBA, Director
- Edward Mathers, Director
- Lynne Sullivan, MST, Director
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Pliant Therapeutics, Inc.
PLN-74809
Pliant Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for the treatment of fibrosis and related diseases. Their lead product candidate, PLN-74809, is currently in Phase 2a trials.
Symbol: PLRX
Recent Price: $12.79
Industry: Biotechnology
CEO: Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Sector: Healthcare
Employees: 166
Address: 260 Littlefield Avenue, South San Francisco, CA 94080
Phone: 650 481 6770
Last updated: 2024-12-31
Renovaro Biosciences Inc.
RENB-HV-01, RENB-HV-12, RENB-HB-01, RENB-DC-11, RENB-DC-12-XX, RENB-HV-21
Renovaro Biosciences Inc. is a pre-clinical stage biotechnology company focused on R&D of pharmaceutical and biological products for treating HIV, HBV, and cancer in the U.S. The company has a robust product pipeline and strategic partnerships, and was formerly known as Enochian Biosciences, Inc.
Symbol: RENB
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. David H. Weinstein
Sector: Healthcare
Employees: 25
Address: 2080 Century Park East, Los Angeles, CA 90067
Phone: 305 918 1980
Last updated: 2024-12-31
Sana Biotechnology, Inc.
N/A
Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.
Symbol: SANA
Recent Price: $1.61
Industry: Biotechnology
CEO: Dr. Steven D. Harr M.D.
Sector: Healthcare
Employees: 328
Address: 188 East Blaine Street, Seattle, WA 98102
Phone: 206 701 7914
Last updated: 2024-12-31
Sorrento Therapeutics, Inc.
G-MAB antibody library, Sofusa drug delivery technology, ZTlido
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focusing on developing therapies for various diseases, including cancer and autoimmune diseases, using innovative antibody libraries and drug delivery systems.
Symbol: SRNE
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Henry H. Ji Ph.D.
Sector: Healthcare
Employees: 949
Address: 4955 Directors Place, San Diego, CA 92121
Phone: 858 203 4100
Last updated: 2024-12-31
Entrada Therapeutics, Inc.
ENTR-601-44
Entrada Therapeutics, Inc. develops endosomal escape vehicle (EEV) therapeutics for treating neuromuscular diseases, with a lead product candidate ENTR-601-44 in preclinical trials for Duchenne muscular dystrophy and myotonic dystrophy type 1.
About | Contact | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About
Symbol: TRDA
Recent Price: $17.37
Industry: Biotechnology
CEO: Mr. Dipal Doshi
Sector: Healthcare
Employees: 168
Address: 6 Tide Street, Boston, MA 02210
Phone: 857 520 9158
Last updated: 2024-12-31
Enanta Pharmaceuticals, Inc.
N/A
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.
About | Leadership | Directors | Contact | Careers | Careers | Culture | About | About | About
Symbol: ENTA
Recent Price: $5.85
Industry: Biotechnology
CEO: Dr. Jay R. Luly Ph.D.
Sector: Healthcare
Employees: 145
Address: 500 Arsenal Street, Watertown, MA 02472
Phone: 617 607 0800
Leadership
- Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
- Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
- Matthew P. Kowalsky, J.D., Chief Legal Officer
- Brendan Luu, Chief Business Officer
- Paul J. Mellett, Chief Financial and Administrative Officer
- Yat Sun Or, Ph.D., Chief Scientific Officer
- Scott T. Rottinghaus, M.D., Chief Medical Officer
- Bruce L.A. Carter, Ph.D., Chairman of the Board
- Mark G. Foletta, Board Member
- Yujiro S. Hata, Board Member
- Kristine Peterson, Board Member
- Lesley Russell, MBChB, MRCPb, Board Member
- Terry Vance, Board Member
Last updated: 2024-12-31